(Q53222352)

12 May 2018

review article

1 reference

title

Biological markers of Alzheimer's disease. (English)

1 reference

12 May 2018

author name string

Hock C

series ordinal

1

1 reference

12 May 2018

publication date

1 March 1998

1 reference

12 May 2018

published in

Neurobiology of Aging

1 reference

12 May 2018

volume

19

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

149-151

1 reference

12 May 2018

The PHA-induced calcium signal in lymphocytes is altered after blockade of K(+)-channels in Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Increased cerebrospinal fluid tau in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Determination of amyloid beta protein precursors harboring active form of proteinase inhibitor domains in cerebrospinal fluid of Alzheimer's disease patients by trypsin-antibody sandwich ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Quantitative changes in the amyloid βA4 precursor protein in Alzheimer cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900010-4

7 January 2021

10.1016/S0197-4580(98)00010-4

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

9558152

1 reference

12 May 2018